Cautionary Statement Regarding Forward-Looking Statements
Certain statements in this communication that are not historical in nature may be considered forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements can be identified by the use of forward-looking or conditional words such as expects, anticipates, believes,
estimates, could, should, can, forecast, intend, look, may, will, remain, confident, commit and
plan or similar expressions. Forward-looking statements include statements relating to the following: (i) the ability of the Company and DS Smith to consummate the Acquisition in a timely manner or at all; (ii) the satisfaction
(or waiver) of conditions to the consummation of the Acquisition; (iii) adverse effects on the market price of the Companys or DS Smiths operating results, including because of a failure to complete the Acquisition; (iv) the
effect of the announcement or pendency of the Acquisition on the Companys or DS Smiths business relationships, operating results and business generally; (v) future capital expenditures, expenses, revenues, economic performance,
synergies, financial conditions, market growth, dividend policy, losses and future prospects; (vi) business and management strategies and the expansion and growth of the operations of the Company group or the DS Smith group; and (vii) the
effects of government regulation on the business of the Company or the DS Smith group. There are many factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among such factors are
changes in the global, political, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax rates and future business combinations or disposals.
These statements are not guarantees of future performance and reflect managements current views and speak only as to the dates the statements are made
and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these statements. By their nature, these forward-looking statements involve known and unknown risks and uncertainties
because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this communication may cause the actual results, performance or achievements of any
such person, or industry results and developments, to be materially different from any results, performance or achievements expressed or implied by such forward-looking statements. No assurance can be given that such expectations will prove to have
been correct and persons reading this communication are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as at the date of this communication. All subsequent oral or written forward-looking
statements attributable to the Company or DS Smith or any persons acting on their behalf are expressly qualified in their entirety by the cautionary statement above. Neither the Company nor DS Smith undertakes any obligation to update publicly or
revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.
IPs
Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and its Quarterly Reports on Form 10-Q for the periods ended March 31, 2024,
and June 30, 2024 contain additional information regarding forward-looking statements and other risk factors with respect to IP.
Additional
Information
This communication may be deemed to be solicitation material in respect of the Combination, including the Share Issuance. In connection
with the Share Issuance, IP filed a Definitive Proxy Statement with the U.S. Securities and Exchange Commission (the SEC) on September 12, 2024 (the Definitive Proxy Statement), as supplemented on
October 1, 2024. To the extent IP effects the Combination as a scheme of arrangement under the laws of the United Kingdom, the Share Issuance does not require registration under the U.S. Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder (the Securities Act), pursuant to an exemption provided by Section 3(a)(10) under the Securities Act. In the event that IP determines to conduct the Combination pursuant to an offer or
otherwise in a manner that is not exempt from the registration requirements of the Securities Act, it will file a registration statement with the SEC containing a prospectus with respect to the Share Issuance. INVESTORS AND STOCKHOLDERS ARE URGED TO
READ THE DEFINITIVE PROXY STATEMENT (AS SUPPLEMENTED), THE SCHEME DOCUMENT, AND OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT IP, THE COMBINATION, THE SHARE ISSUANCE, AND RELATED MATTERS.
Investors and stockholders will be able